Covered recipient · General Payments record
PRIYANKA KAKAR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,066.27
- Reported across 142 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $165.14 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $32.08 | 2 |
| Acerta Pharma LLC | $30.95 | 2 |
| Novo Nordisk AS | $30.55 | 2 |
| Exact Sciences Corporation | $20.40 | 1 |
| HEARTFLOW, INC. | $18.83 | 1 |
| ABBVIE INC. | $17.17 | 1 |
| Lilly USA, LLC | $15.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.17 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104020619 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.81 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105500460 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.14 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104286460 | CMS |
| Exact Sciences Corporation | $20.40 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114725402 | CMS |
| GlaxoSmithKline, LLC. | $15.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116460859 | CMS |
| GlaxoSmithKline, LLC. | $16.43 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116192762 | CMS |
| HEARTFLOW, INC. | $18.83 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154181912 | CMS |
| Lilly USA, LLC | $15.16 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135288106 | CMS |
| Novo Nordisk Inc | $15.97 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096582727 | CMS |
| Novo Nordisk Inc | $14.58 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097504633 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.